Methodological Insights into Herbal Medicine Trials for Obesity: A Comprehensive Scoping Review

Introduction

Obesity affects millions of people worldwide and is associated with serious health consequences such as cardiovascular disease, diabetes, and hypertension. Standard pharmacological approaches are a mainstay for obesity management; however, concerns over adverse effects and patient safety have led to renewed interest in herbal medicine interventions. Herbal approaches have been used for centuries in traditional systems of medicine, and modern RCTs now attempt to validate their efficacy for weight loss and metabolic improvement.

Clinical trials testing herbal formulations confront unique challenges—ranging from diverse botanical preparations (single herbs vs. mixtures) to variations in intervention duration, dosage, and the integration of lifestyle modifications. In this comprehensive review, we summarize and analyze the methodologies used in these anti-obesity RCTs to highlight common research designs, measurement outcomes, and strategies for safety and efficacy assessment.

Methodological Approaches in Herbal Medicine RCTs

Herbal medicine trials for obesity have been conducted with wide variations in design. Nearly 99 RCTs have been identified with sample sizes ranging from 8 to 182 participants and study durations from 14 days to 56 weeks. The interventions may use either a single herb or a mixture of herbs administered in various formulations (capsules, powders, beverages, decoctions, or even confectionery). Many studies also incorporate lifestyle modifications such as dietary interventions (e.g., restricted calorie diets or portion-controlled diets) and physical exercise programs to complement the herbal treatment.

Primary Methodological Components

• Participant Selection:
  Most RCTs recruit adults with a body mass index (BMI) of 25 kg/m² or higher. Some studies further classify participants as obese (BMI ≥30 kg/m²) or overweight, and a number include populations with complications such as metabolic syndrome or type 2 diabetes.

• Intervention Design:
  Herbal interventions are categorized into two types:

  • Single Herb Interventions: These trials evaluate the efficacy of one herbal extract (e.g., green tea extract, bitter orange, or aloe).
  • Herbal Mixture Interventions: In these studies, combinations of botanicals are tested. The dosages and preparations are carefully documented. For example, one trial might use a combination product containing extracts of Moringa oleifera, Murraya koenigii, and Curcuma longa.

• Adjunct Lifestyle Modifications:
  Approximately half of the studies integrate dietary modifications—most commonly a restricted calorie diet. In addition, some trials also include structured physical exercise regimens ranging from light to moderate intensity to optimize weight loss outcomes.

• Outcome Measurements:
  The common measures include:

  • Anthropometric Measurements: Changes in BMI, weight, waist circumference, hip circumference, and body fat composition are routinely collected.
  • Radiological Assessments: A subset of studies employs dual-energy X-ray absorptiometry (DEXA) or computed tomography (CT) scans to assess body composition.
  • Laboratory Parameters: Many trials monitor biochemical markers such as lipid profiles, hormone levels (insulin, leptin, adiponectin), and inflammatory markers (C-reactive protein).
  • Patient-Reported Outcomes: Quality-of-life questionnaires and self-reported assessments of energy, satiety, and stress are instrumental in gauging the broader impact of interventions.

Data Collection and Analysis Tools

Many studies adhere to internationally recognized guidelines, using standardized tools for measurement. Devices such as bioelectrical impedance analyzers offer rapid assessment of body fat composition and are used in over 50% of the RCTs. Safety monitoring is integral, with adverse events recorded through both clinical observation and laboratory screening.

Below is a simplified data table summarizing key characteristics extracted from studies of herbal medicine for obesity:

Discussion

The methodologies employed in herbal medicine RCTs for obesity reveal both strengths and challenges within the research landscape. Standardization of intervention details such as botanical extraction processes, precise dosages, and consistent formulation remains a priority. Nearly 50% of the trials have adhered to international clinical trial guidelines borrowed from pharmaceutical studies. However, variability persists particularly in the measurement of long-term weight maintenance and metabolic outcomes.

Researchers are increasingly called upon to integrate multidisciplinary approaches. For example, the involvement of dietitians and exercise physiologists helps to ensure that herbal interventions are implemented alongside proven lifestyle modifications. Furthermore, a thorough safety monitoring framework—which includes both biochemical and clinical endpoints—is imperative due to potential herb–drug interactions and adverse reactions.

The data show that while the majority of trials effectively measure primary outcomes such as weight loss and BMI reductions, there is less uniformity in assessing secondary outcomes (e.g., changes in body fat distribution or metabolic markers). Addressing these gaps will be crucial to advancing the clinical acceptance and utility of herbal anti-obesity formulations.

Future trials should also aim to improve participant retention and minimize loss to follow-up. Extended follow-up periods, ideally beyond six months, are recommended to properly assess the sustainability of weight loss and overall metabolic improvement.

Relevance for Future Research

Understanding the methodological nuances in herbal medicine RCTs is essential for designing robust future studies. Researchers are encouraged to:

• Standardize herbal preparation and dosing protocols.
• Incorporate comprehensive lifestyle interventions.
• Utilize validated measurement tools for anthropometric, radiological, laboratory, and patient-reported outcomes.
• Emphasize long-term follow-up to assess sustainability of benefits.
• Strengthen safety monitoring frameworks to capture adverse effects accurately.

Such improvements will enhance the quality and comparability of trials, paving the way for herbal medicines to become a reliable part of obesity management strategies.

Frequently Asked Questions (FAQ)

What defines herbal medicine in the context of obesity clinical trials?
Herbal medicine, as defined by the World Health Organization, refers to herbs, herbal materials, herbal preparations, and finished herbal products that contain parts of plants or combinations thereof as active ingredients. In obesity trials, these interventions can be delivered as single extracts or multi-herb mixtures.

How are the outcomes typically measured in these trials?
Common outcome measures in herbal medicine RCTs for obesity include anthropometric markers (BMI, weight, waist and hip circumferences), body fat composition (often measured by bioelectrical impedance or DEXA), various biochemical parameters (lipid profiles, hormone levels, inflammatory markers), and quality-of-life assessments.

Why are lifestyle modifications often included along with herbal interventions?
Lifestyle modifications such as diet and exercise are key components of weight management. Incorporating these strategies can enhance the effectiveness of herbal interventions by addressing both the physiological and behavioral aspects of obesity.

What challenges exist in standardizing methods for herbal medicine trials?
Challenges include variability in herbal extraction processes, differences in formulation (capsules, powders, beverages), diverse dosages and treatment durations, and inconsistent measurement methods for outcomes. Standardization is critical for ensuring reproducibility and comparability of results.

How can future research in this field be improved?
Future research can benefit from standardized protocols, multidisciplinary collaboration, longer follow-up durations, robust safety monitoring, and the use of validated measurement tools. This would help to overcome current methodological challenges and provide clearer evidence of efficacy and safety.

References

1. Chan, J. S. W., Lau, M. S., Muhamad Rosli, S., Mustapha, K., Wan Seman, W. N., Ali, N. H., Tan, T. Y. C., & Syed Mohamed, A. F. (2024). Methodological insights into intervention and outcomes in randomized controlled trials of herbal medicine for obesity: A scoping review. Therapeutic Advances in Chronic Disease

2. Qin, Z.-J., Shi, Z.-M., Li, L.-J., Wei, X., Hu, H.-L., Wei, W., Xie, Z.-Y., Ji, H.-X., & Wei, Y.-H. (2024). Metformin for neurocognitive dysfunction in schizophrenia: A systematic review. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2024.1540153

3. Zafar, R., Rehman, I. U., Shah, Y., Ming, L. C., Goh, K. W., Suleiman, A. K., & Khan, T. M. (2025). Impact of pharmacist-led intervention for reducing drug-related problems and improving quality of life among chronic kidney disease patients: A randomized controlled trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0317734

4. Mapesi, H., Rohacek, M., Vanobberghen, F., Gupta, R., Wilson, H. I., Lukau, B., Amstutz, A., Lyimo, A., Muhairwe, J., Senkoro, E., Byakuzana, T., Nkouabi, J., Mbunda, G., Siru, J., Tarr, A., Ramapepe, E., Mphunyane, M., Oehri, J., Nemtsova, V., Yan, X., Bresser, M., Glass, T. R., Paris, D. H., Fink, G., Gingo, W., Labhardt, N. D., Burkard, T., & Weisser, M. (2025). Treatment strategies to control blood pressure in people with hypertension in Tanzania and Lesotho: A randomized clinical trial. JAMA Cardiology